Who invested in Circle Pharma?
Circle Pharma's investors include Eli Lilly, Mission Bay Capital, RA Capital Management, Pfizer and Mission BioCapital.

United States · Series E startup
Funding summaryUpdated 26 Oct 2026
$187Mraised across 4 rounds since 2014, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $63M sold, first sale Jun 2024
Reported by FinSMEsSEC filing: $3.8M sold, first sale Sept 2016
From Circle Pharma's own website: 9 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Circle Pharma's investors include Eli Lilly, Mission Bay Capital, RA Capital Management, Pfizer and Mission BioCapital.
Circle Pharma has raised $187M across 4 rounds since 2014. One round did not disclose an amount, so the total is a floor.
Circle Pharma's most recent round was a Series E of $93M in Sept 2026.
Its most recent round, $93M in Sept 2026, is also its largest on record.
Circle Pharma's first round on record, in Sept 2014, was backed by Pfizer and Mission Bay Capital.
Circle Pharma's latest named round is a Series E, in Sept 2026.
Circle Pharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.